Streetbeat News

Products Services

AAPL

AMZN

GLD

GOOG

META

MSFT

NVDA

QQQ

SLV

SPY

TSLA

USO

The article discusses the current market conditions, focusing on the PCE data, personal spending, and income figures, as well as the impact of the recent presidential debate on the market. It also highlights the money flows in major tech stocks and ETFs, and provides guidance on protection bands for investors.

Portfolio Pulse from The Arora Report

June 28, 2024 | 3:08 pm

AYRWF

GTBIF

HITI

ITHUF

Florida is seeing a surge in cannabis retail activity as the state prepares for a potential legalization of recreational marijuana. Green Thumb Industries and iAnthus Capital Holdings have opened new dispensaries, while AYR Wellness and High Tide Inc. are expanding their retail footprint in other states and Canada.

Portfolio Pulse from Jelena Martinovic

June 28, 2024 | 3:05 pm

BROS

DHR

PCG

RIVN

TJX

Benzinga's Stock Whisper Index highlights five stocks that are gaining interest among investors: TJX Companies, Dutch Bros, Rivian Automotive, Pacific Gas & Electric, and Danaher Corporation. Key developments include TJX's joint venture with Grupo Axo, Dutch Bros' new board member and positive analyst rating, Rivian's $5 billion investment with Volkswagen, analyst updates on Pacific Gas & Electric, and Danaher's FDA approval for a Hepatitis C test.

Portfolio Pulse from Chris Katje

June 28, 2024 | 3:03 pm

CGON

Nine analysts have provided varied opinions on CG Oncology (NASDAQ:CGON) over the past quarter, with the majority being bullish. The average 12-month price target is $68.33, slightly down from the previous $69.67. Key analysts from firms like B of A Securities, HC Wainwright & Co., and Goldman Sachs have maintained or raised their ratings, with price targets ranging from $50.00 to $75.00. CG Oncology is a late-stage clinical biopharmaceutical company focused on bladder cancer treatments, showing strong revenue growth but facing profitability challenges.

Portfolio Pulse from Benzinga Insights

June 28, 2024 | 3:01 pm

JNJ

Johnson & Johnson announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Balversa (Erdafitinib) for the treatment of adult patients.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 2:58 pm

APLS

Apellis shares are trading lower after the company announced that the CHMP has adopted a negative opinion on the marketing authorization application of intravitreal pegcetacoplan for the treatment of geographic atrophy.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 2:55 pm

WBD

The Esports World Cup has announced a new multi-platform partnership with Warner Bros. Discovery to expand its audience reach.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 2:49 pm

COSM

Cosmos Health (NASDAQ:COSM) shares surged 65% after the company signed an exclusive distribution agreement with Pharmalink for its Sky Premium Life products in the UAE. The agreement includes an initial order of 130,000 units and an expected total of 500,000 units in the first year, with projections of over 3 million units in the next five years.

Portfolio Pulse from Dylan Berman

June 28, 2024 | 2:41 pm

GOOG

GOOGL

Google and TikTok have banned Done Global from advertising ADHD medications on their platforms following a federal crackdown on the telehealth company's distribution practices. The Justice Department has charged several individuals associated with Done Global for illegally distributing controlled substances. Despite losing certification, Done continued heavy ad spending, which has now been halted by Google and TikTok.

Portfolio Pulse from Vandana Singh

June 28, 2024 | 2:41 pm

BABA

BIDU

PGJ

SOCL

Baidu Inc. (NASDAQ:BIDU) shares are trading higher in premarket after unveiling an upgraded AI model, Ernie 4.0 Turbo. The new model aims to compete with international counterparts and is part of Baidu's strategy to stay competitive in China's AI market. The company also announced enhancements to its PaddlePaddle AI ecosystem. OpenAI's exit from China presents an opportunity for Baidu and other domestic AI firms like Alibaba Group Holding Ltd. (NYSE:BABA) to attract new users. Investors can gain exposure to Baidu via Invesco Golden Dragon China ETF (NASDAQ:PGJ) and Global X Social Media ETF (NASDAQ:SOCL).

Portfolio Pulse from Shivani Kumaresan

June 28, 2024 | 2:40 pm